Lv11
30 积分 2023-09-15 加入
Development and validation of pharmacokinetics assays for a novel HER2-targeting antibody-drug conjugate (SHR-A1201): Application to its dose-escalation pharmacokinetic study
1小时前
已完结
A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
1小时前
已完结
IL-23在自身免疫性疾病中的调控机制及潜在应用。
1个月前
已完结
HER2基因扩增或其编码的蛋白过表达型转移性结直肠癌的靶向治疗进展
4个月前
已完结
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial
4个月前
已完结
Her-2阳性结直肠癌的诊治进展
4个月前
已完结
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)
4个月前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
1年前
已关闭
皖公网安备34019202002308
